Fox Run Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,428
| Closed | -$229K | – | 1030 |
|
|
2025
Q1 | $229K | Buy |
+13,428
| New | +$229K | 0.04% | 759 |
|
|
2024
Q1 | – | Sell |
-14,534
| Closed | -$612K | – | 916 |
|
|
2023
Q4 | $612K | Buy |
+14,534
| New | +$612K | 0.16% | 226 |
|
|
2023
Q2 | – | Sell |
-12,882
| Closed | -$200K | – | 815 |
|
|
2023
Q1 | $200K | Buy |
12,882
+102
| +0.8% | +$1.58K | 0.07% | 532 |
|
|
2022
Q4 | $227K | Buy |
+12,780
| New | +$227K | 0.09% | 450 |
|
|
2022
Q1 | – | Sell |
-10,803
| Closed | -$92K | – | 603 |
|
|
2021
Q4 | $92K | Sell |
10,803
-3,109
| -22% | -$26.5K | 0.05% | 423 |
|
|
2021
Q3 | $121K | Buy |
+13,912
| New | +$121K | 0.08% | 414 |
|